For many patients with type 2 diabetes, having to inject basal insulin every day is a burdensome fact of life, but Novo Nordisk is trying to change that. The Danish drugmaker has reported the first ...

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next year. The ...

Whether you have fair skin, a darker skin tone or land somewhere in the middle, it’s important to protect your skin from the sun. There’s no worse way to ruin an amazing day at the beach than getting ...